What is the main business of Apteka Jana?

The main business activity of Apteka Jana focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 23, 2011.

Where is the headquarters located?

The headquarters is located at: Św. Barbary 73, 42-226 Częstochowa.

What is the share capital?

The share capital of the company is PLN 38,000 (approx. $10,265).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of USD 359,128, representing an increase of 2.5% compared to 2024.

No, in 2025 the company was not profitable, reporting a net loss of USD 2,227. For comparison, in 2024 the loss was USD 11,773, meaning the company reduced its loss by 81.1%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to USD 292,558 in 2025, representing 81% of all operating expenses.

Apteka Janasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2011-12-23

Share capital

38,000.00 PLN

Registered address

św. Barbary 73, 42-226 Częstochowa, Poland

Electronic delivery address

AE:PL-80641-62773-GJCRH-20

Financials

Revenue history (in k)

Filing timeliness

5 of 6 financial statements were filed late (the longest delay 147 days for 2023).

202515/10/2026
202426/08/2025
202309/12/2024
202209/11/2023
202119/10/2022
202007/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 359.13kMedianUSD 919.05kAverageUSD 25.83m

Net profit

This companyUSD -2.23kMedianUSD 14.92kAverageUSD 2.77m

Operating costs

This companyUSD 359.47kMedianUSD 873.06kAverageUSD 21.43m

Assets

This companyUSD 79.33kMedianUSD 897.46kAverageUSD 31.52m

Industry

Authorized Representatives

Janusz Wójcik – President

Manner of representation

President of the Management Board, or two members of the management board jointly, or a member of the management board jointly with a commercial proxy if a commercial proxy has been appointed.

Ownership

Owner	Shares	Share value	Stake
Janusz Wójcikage 72	380	$10,264.72	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2012-06-01.

Bank Millennium
12 1160 2202 0000 0002 0685 0566

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $13,132.

Grant date	Purpose	Gross amount	Granting body
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	––	Prezes Zakładu Ubezpieczeń Społecznych
Jun 10, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	––	Prezydent Miasta Częstochowa
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	––	Prezes Zakładu Ubezpieczeń Społecznych

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Biomarsp. z o.o.	$909,113.28	biomar.pl
Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o.	$893,738.50	lekinatury.pl
Optiferricsp. z o.o.	$816,162.17	optiferric.com
Zeptor Polskasp. z o.o.	$748,374.79	zeptor.pl
Human BiomeS.A.	$583,508.16	human-biome.com
Hauster sp. z o.o.sp. k.	$577,912.26	hauster.pl
PLON Pharmsp. z o.o.	$524,792.98	plonpharm.pl
DR Andresp. z o.o.	$453,987.42	drandre.pl
F1 PharmaS.A.	$272,113.66	f1pharma.pl
Ti-Comsp. z o.o.	$157,549.77	ticomglobal.com